Analyst IMS Investment Management Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,181
Closed -$208K 133
2024
Q3
$208K Hold
7,181
0.01% 134
2024
Q2
$201K Buy
+7,181
New +$198K 0.01% 129
2020
Q4
Sell
-12,137
Closed -$422K 91
2020
Q3
$422K Buy
+12,137
New +$426K 0.09% 79
2020
Q2
Sell
-16,338
Closed -$506K 90
2020
Q1
$506K Sell
16,338
-4,961
-23% -$169K 0.16% 65
2019
Q4
$410K Hold
21,299
0.11% 87
2019
Q3
$723K Buy
21,299
+1,054
+5% +$38.3K 0.21% 59
2019
Q2
$832K Sell
20,245
-4,216
-17% -$167K 0.25% 59
2019
Q1
$986K Sell
24,461
-23,829
-49% -$954K 0.3% 56
2018
Q4
$1.99K Buy
48,290
+20,308
+73% +$843K 0.32% 33
2018
Q3
$1.16K Sell
27,982
-4,096
-13% -$158K 0.19% 52
2018
Q2
$1.11M Sell
32,078
-56,467
-64% -$1.93M 0.34% 51
2018
Q1
$2.98M Sell
88,545
-55,282
-38% -$1.9M 0.94% 24
2017
Q4
$4.94M Sell
143,827
-1,747
-1% -$59.6K 1.51% 18
2017
Q3
$4.91M Buy
145,574
+727
+0.5% +$23.4K 1.61% 20
2017
Q2
$4.62M Sell
144,847
-959
-0.7% -$30.2K 1.64% 19
2017
Q1
$4.74M Sell
145,806
-1,224
-0.8% -$38.6K 1.85% 16
2016
Q4
$4.53M Sell
147,030
-24,035
-14% -$734K 1.98% 13
2016
Q3
$5.5M Sell
171,065
-6,878
-4% -$230K 2.33% 13
2016
Q2
$5.94M Sell
177,943
-4,009
-2% -$128K 2.51% 11
2016
Q1
$5.12M Sell
181,952
-3,760
-2% -$107K 2.2% 14
2015
Q4
$5.69M Buy
185,712
+1,318
+0.7% +$41.5K 2.37% 12
2015
Q3
$5.5M Sell
184,394
-6,533
-3% -$209K 2.32% 12
2015
Q2
$6.07M Sell
190,927
-8,013
-4% -$261K 2.36% 10
2015
Q1
$6.57M Buy
198,940
+1,396
+0.7% +$44.4K 2.55% 8
2014
Q4
$5.84M Buy
+197,544
New +$5.66M 2.24% 12

Other funds holding PFE

Analyst IMS Investment Management Services's PFE Position: Q4 2024 in Review

Analyst IMS Investment Management Services sold out of Pfizer (PFE) in Q4 2024, closing a stake of 7,181 shares — an estimated $208K sold.

Analyst IMS Investment Management Services first reported a position in PFE in Q4 2014 and held it in 25 quarters. The position peaked at $6.57M in Q1 2015. 2,995 funds tracked by Wall St. Rank hold PFE as of Q4 2024.

  • Analyst IMS Investment Management Services reported no remaining Pfizer position as of Q4 2024 after selling out during the quarter.
  • Analyst IMS Investment Management Services sold 7,181 Pfizer shares in Q4 2024, an estimated $208K.
  • Analyst IMS Investment Management Services first reported a position in Pfizer in Q4 2014 and held it in 25 quarters.
  • Analyst IMS Investment Management Services's Pfizer position peaked at $6.57M in Q1 2015.
  • 2,995 funds tracked by Wall St. Rank held Pfizer as of Q4 2024.

Based on Analyst IMS Investment Management Services's 13F filing for Q4 2024, filed 10 Feb 2025.